Hollywood's Psychedelics Craze, Is Drew Barrymore Joining The Trend?

Former child star and one of the beloved Charlie’s Angels, Drew Barrymore hinted that she would consider MDMA or psilocybin therapy “as a way to get to some state where I could see things in a different way.”

As hostess of The Drew Barrymore Show, she encourages guests to open up emotionally. 

In a recent interview with NY Magazine and Vulture, Barrymore, who has two children, disclosed that she has not been in an intimate relationship since she divorced Will Kopelman in 2016 and that she wants to understand the reason why she’s so “tired and exhausted” with romance. 

Barrymore said she’s spent a great part of her life “loving romance and drama and all of that,” and that she genuinely burnt herself out on it.

Prior to her marriage to Kopelman, she was married to former MTV star Tom Green (1994 to 1996,) and previously dated David Arquette, Luke Wilson and Justin Long.

Searching For Fulfillment

Barrymore became worldwide known when she starred in Steven Spielberg’s E.T. in 1982. She was seven at that time. 

Indeed, she has several times opened up about the turbulence of child stardom, working in the industry as a teen and being institutionalized at 13 by her mother, reported Huffington Post.

She has also spoken about her past substance abuse issues, recently telling The Los Angeles Times that her way of coping with her “cripplingly difficult” divorce from Kopelman was by drinking.

Now, Barrymore says, she is “curious to examine” why she is not open to a relationship. “I really think I have some serious shit buried. And I don’t know if it’s like I need to try an MDMA treatment or psilocybin as a way to get to some state where I could see things in a different way.”

Since the beginning of the Psychedelics Renaissance, several famous and wealthy people have shared their experiences and support for engagement with mind-altering substances. 

A controversial issue, since psychedelics work within the brain and can lead to unpleasant experiences -aka bad trips- companies and organizations are working to provide people with the chance to get acquainted with the substances and have certain control over their experience.

The field is immense, with immediate offerings from retreats in countries where psychedelics are legal to U.S. states providing a regulatory framework for psychedelic-assisted therapies.

Psychedelics, while federally illegal, MDMA therapy is expected to be approved by the FDA sometime in 2024 with psilocybin to follow soon thereafter. The space is preparing for all aspects relating to the therapeutic, ethical and safe use of the compounds.

See also: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations

Photo by Caroline Bonarde Ucci.